PTLF — Petlife Pharmaceuticals Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.02m
- $0.82m
Annual cashflow statement for Petlife Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2013 August 31st | 2014 August 31st | 2015 August 31st | 2016 August 31st | 2017 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.62 | -1.51 | -1.93 | -3.69 | -23.3 |
Non-Cash Items | 1.16 | 1.24 | 1.55 | 0.742 | 22.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.324 | — | 0.361 | 2.79 | 0.453 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.137 | -0.267 | -0.022 | -0.152 | -0.319 |
Capital Expenditures | 0 | — | -0.001 | 0 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0.1 | 0 | — | — |
Sale of Business | |||||
Cash from Investing Activities | 0 | 0.1 | -0.001 | 0 | — |
Financing Cash Flow Items | 0.007 | — | 0.01 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.137 | 0.174 | 0.016 | 0.153 | 0.372 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0 | 0.007 | -0.007 | 0.001 | 0.053 |